Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapy.
Kong VC, Dang J, Li W, Navarro I, Padayachee J, Malkov V, Winter J, Raman S, Berlin A, Catton C, Warde P, Chung P. Kong VC, et al. Among authors: raman s. Tech Innov Patient Support Radiat Oncol. 2022 Mar 2;21:64-70. doi: 10.1016/j.tipsro.2022.02.003. eCollection 2022 Mar. Tech Innov Patient Support Radiat Oncol. 2022. PMID: 35252598 Free PMC article.
Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac.
Dang J, Kong V, Li W, Navarro I, Winter JD, Malkov V, Berlin A, Catton C, Padayachee J, Raman S, Warde P, Chung P. Dang J, et al. Among authors: raman s. Tech Innov Patient Support Radiat Oncol. 2022 Aug 27;23:41-46. doi: 10.1016/j.tipsro.2022.08.005. eCollection 2022 Sep. Tech Innov Patient Support Radiat Oncol. 2022. PMID: 36105770 Free PMC article.
Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapy.
Li W, Padayachee J, Navarro I, Winter J, Dang J, Raman S, Kong V, Berlin A, Catton C, Glicksman R, Malkov V, McPartlin A, Kataki K, Lindsay P, Chung P. Li W, et al. Among authors: raman s. Tech Innov Patient Support Radiat Oncol. 2023 May 13;27:100212. doi: 10.1016/j.tipsro.2023.100212. eCollection 2023 Sep. Tech Innov Patient Support Radiat Oncol. 2023. PMID: 37265510 Free PMC article.
Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer.
Navarro-Domenech I, Arulanantham S, Liu ZA, Tjong M, Kong V, Malkov V, Tadic T, Fleshner N, Kulkarni G, Zlotta AR, Catton C, Berlin A, Sridhar S, Jiang DM, Chung P, Raman S. Navarro-Domenech I, et al. Among authors: raman s. Radiat Oncol. 2023 Sep 20;18(1):154. doi: 10.1186/s13014-023-02338-w. Radiat Oncol. 2023. PMID: 37730609 Free PMC article.
A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol.
Palma DA, Giuliani ME, Correa RJM, Schneiders FL, Harrow S, Guckenberger M, Zhang T, Bahig H, Senthi S, Chung P, Olson R, Lock M, Raman S, Bauman GS, Lok BH, Laba JM, Glicksman RM, Nguyen TK, Lang P, Helou J, Goodman CD, Mendez LC, van Rossum PSN, Warner A, Gaede S, Allan AL. Palma DA, et al. Among authors: raman s. BMC Palliat Care. 2024 Sep 7;23(1):223. doi: 10.1186/s12904-024-01548-7. BMC Palliat Care. 2024. PMID: 39244532 Free PMC article.
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.
Glicksman RM, Metser U, Vines D, Valliant J, Liu Z, Chung PW, Bristow RG, Finelli A, Hamilton R, Fleshner NE, Perlis N, Zlotta AR, Green D, Bayley A, Helou J, Raman S, Kulkarni G, Catton C, Lam T, Chan R, Warde P, Gospodarowicz M, Jaffray DA, Berlin A. Glicksman RM, et al. Among authors: raman s. Eur Urol. 2021 Sep;80(3):374-382. doi: 10.1016/j.eururo.2021.02.031. Epub 2021 Mar 6. Eur Urol. 2021. PMID: 33685838 Clinical Trial.
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.
Glicksman RM, Ramotar M, Metser U, Chung PW, Liu Z, Vines D, Finelli A, Hamilton R, Fleshner NE, Perlis N, Zlotta AR, Bayley A, Helou J, Raman S, Kulkarni G, Catton C, Lam T, Chan R, Warde P, Gospodarowicz M, Jaffray DA, Berlin A. Glicksman RM, et al. Among authors: raman s. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):693-704. doi: 10.1016/j.ijrobp.2022.06.080. Epub 2022 Aug 27. Int J Radiat Oncol Biol Phys. 2022. PMID: 36031465 Clinical Trial.
1,686 results